madal H. Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload. Am J Physiol Heart Circ Physiol 303: H66 -H74, 2012. First published April 27, 2012; doi:10.1152/ajpheart.00724.2011.-Transgenic mice with cardiac-specific expression of a peptide inhibitor of G protein-coupled receptor kinase (GRK)3 [transgenic COOHterminal GRK3 (GRK3ct) mice] display myocardial hypercontractility without hypertrophy and enhanced ␣1-adrenergic receptor signaling. A role for GRK3 in the pathogenesis of heart failure (HF) has not been investigated, but inhibition of its isozyme, GRK2, has been beneficial in several HF models. Here, we tested whether inhibition of GRK3 modulated evolving cardiac hypertrophy and dysfunction after pressure overload. Weight-matched male GRK3ct transgenic and nontransgenic littermate control (NLC) mice subjected to chronic pressure overload by abdominal aortic banding (AB) were compared with sham-operated (SH) mice. At 6 wk after AB, a significant increase of cardiac mass consistent with induction of hypertrophy was found, but no differences between GRK3ct-AB and NLC-AB mice were discerned. Simultaneous left ventricular (LV) pressure-volume analysis of electrically paced, ex vivo perfused working hearts revealed substantially reduced systolic and diastolic function in NLC-AB mice (n ϭ 7), which was completely preserved in GRK3ct-AB mice (n ϭ 7). An additional cohort was subjected to in vivo cardiac catheterization and LV pressure-volume analysis at 12 wk after AB. NLC-AB mice (n ϭ 11) displayed elevated end-diastolic pressure (8.5 Ϯ 3.1 vs. 2.9 Ϯ 1.2 mmHg, P Ͻ 0.05), reduced cardiac output (3,448 Ϯ 323 vs. 4,488 Ϯ 342 l/min, P Ͻ 0.05), and reduced dP/dtmax and dP/dtmin (both P Ͻ 0.05) compared with GRK3ct-AB mice (n ϭ 16), corroborating the preserved cardiac structure and function observed in GRK3ct-AB hearts assessed ex vivo. Increased cardiac mass and myocardial mRNA expression of ␤-myosin heavy chain confirmed the similar induction of cardiac hypertrophy in both AB groups, but only NLC-AB hearts displayed significantly elevated mRNA levels of brain natriuretic peptide and myocardial collagen contents as well as reduced ␤1-adrenergic receptor responsiveness to isoproterenol, indicating increased LV wall stress and the transition to HF. Inhibition of cardiac GRK3 in mice does not alter the hypertrophic response but attenuates cardiac dysfunction and HF after chronic pressure overload.
G PROTEIN-COUPLED RECEPTORS (GPCRs) comprise a major receptor family involved in most fundamental biological signaling processes (3, 31) . In the heart, GPCR signaling may lead to the modulation of heart rate and contractility via ␤-and ␣-adrenergic receptors (␤ARs and ␣ARs) or changes in structure by inducing events such as cell growth or apoptosis (4) . Desensitization and downregulation of cardiac ␤ARs in heart failure (HF) are caused by GPCR kinase [G protein-coupled receptor kinase (GRK)]-catalyzed phosphorylation of the agonist-activated receptors (11) . Four different GRK isoforms have been found in myocardial tissue, i.e., GRK2 [␤AR kinase (␤ARK)1], GRK3 (␤ARK2), GRK5, and GRK6 (26) . GRK2 and GRK3 constitute the ␤ARK subfamily among the different GRK isoforms and, unlike the others, possess a COOH-terminal pleckstrin homology domain, which is important for targeting these kinases to the plasma membrane (15, 27) .
GRK2 is the most abundant and best-studied GRK isoform in myocardial tissue (31) . Myocardial GRK2 levels are elevated in several animal models of cardiac hypertrophy, ischemia, and HF (2, 6, 21, 25, 30, 34) . Cardiac expression of the COOH-terminal membrane-targeting domain of GRK2 (GRK2ct) to inhibit GRK2 delays the onset of HF and reduces mortality in several murine HF models (10, 16, 29) . Moreover, the levels of GRK2 inhibition are inversely correlated with the degree of cardiac dysfunction in GRK2ct mice subjected to chronic pressure overload (33) . Consistently, enhanced expression of GRK2 is found in human HF (34, 35) . Although GRK2 and GRK3 display receptor selectivity in vitro, the conclusions drawn from studies of GRK2ct in vivo may be limited by uncertainty as to whether the GRK2ct peptide confers selective inhibition of endogenous GRK2.
The role of GRK3 in cardiac function or failure is less well studied. Previous data from studies in hybrid transgenic mice have pointed to an important and distinct role of GRK3 in regulating ␣ 1 AR-mediated cardiac hypertrophy (9) . A recent report (36) from our laboratory has shown distinct receptor selectivity for GRK2 and GRK3 in cardiac myocytes. GRK3 and a competitive inhibitor (GRK3ct) much more potently regulated endogenous endothelin (ET) receptor and ␣ 1 AR signaling in adult rat cardiac myocytes than GRK2 and GRK2ct. Conversely, GRK2 exhibited substantially higher efficacy at ␤ 1 ARs than GRK3, corroborating a previous study (14) suggesting distinct receptor specificities for GRK2 and GRK3. These findings demonstrate the principal role of GRK3 in the regulation of ET receptor and ␣ 1 AR signaling and that of GRK2 in the regulation of ␤ 1 AR signaling in cardiac myocytes and provide evidence of distinct roles of the two kinases in the regulation of cardiac function (36) .
We (38) have recently shown that transgenic mice with cardiac-restricted expression of GRK3ct (Tg-GRK3ct mice) exhibit a phenotype with elevated blood pressure and hypercontractility and enhanced ␣ 1 AR signaling. Importantly, no cardiac hypertrophy could be discerned. Interestingly, mice with cardiac-restricted overexpression of ␣ 1A AR display a similar phenotype with enhanced inotropy at baseline (19) . Moreover, that transgenic model rescued cardiac dysfunction after pressure overload (7) . Thus, we hypothesized that inhibition of cardiac GRK3 may confer protection against cardiac dysfunction and comprehensively assessed cardiac function in Tg-GRK3ct mice and nontransgenic littermate control (NLC) mice subjected to chronic pressure overload.
MATERIALS AND METHODS
Animal model and study protocol. Tg-GRK3ct mice with cardiacrestricted overexpression of the COOH-terminal pleckstrin homology domain of GRK3 and NLC mice were both generated from C56BL/ 6-CBA hybrid mice as previously described (38) . Chronic pressure overload was induced by abdominal aortic banding (AB) (5) . Briefly, suprarenal aortic constriction was performed by tightening a suture around the abdominal aorta and a 26-gauge blunted needle, which was subsequently removed. Seven-to eight-week-old weight-matched male Tg-GRK3ct mice and NLC mice were randomized to either AB [GRK3ct-AB (n ϭ 32) and NLC-AB (n ϭ 26)] or sham operation [SH; GRK3ct-SH (n ϭ 21) and NLC-SH (n ϭ 18)] and analyzed 6 wk after surgery. A second cohort [GRK3ct (n ϭ 21) and NLC (n ϭ 18)] was evaluated at 12 wk after surgery to evaluate the transition to cardiac dysfunction. This study conformed with the American Physiological Society's "Guiding Principles in the Care and Use of Animals" and was approved by the National Animal Experimentation Board.
Assessment of cardiovascular function in vivo and ex vivo. At 6 wk after surgery, ex vivo perfused (working mode), electrically paced (8 Hz) hearts from AB and SH Tg-GRK3ct and NLC mice were subjected to simultaneous recordings of left ventricular (LV) pressure and volume during stepwise increase of filling pressures (12) . At 12 wk after surgery, closed-chest in vivo cardiac function was determined in a second cohort of anesthetized freely breathing mice (0.8 -1% isoflurane). A 1.4-Fr combined micromanometer-tipped conductance catheter (SPR-839, Millar Instruments, Houston, TX) was retrogradely advanced via the right carotid artery, and steady-state simultaneous recordings of LV pressure and volume were performed at heart rates stabilized above 450 beats/min (38) . Analysis of the obtained LV pressure-volume curves was performed offline in a blinded fashion. A third group of NLC and GRK3ct mice (n ϭ 5 of each line) was subjected to consecutive invasive measurement of blood pressure proximal and distal to the site of constriction 1 wk after AB. Here, the same catheter as before mentioned was advanced to the descending aorta via the left carotid artery and thereafter to the common iliac artery via femoral artery access. The AB-induced pressure gradient was calculated in each individual animal as the blood pressure measured in the aorta minus that in the iliac artery.
Molecular analysis of cardiac tissues. Cardiac tissues were snap frozen in liquid nitrogen immediately after excision of the heart. Total Fig. 1 . Myocardial mRNA levels of ␤-myosin heavy chain (␤-MHC; A) and brain natriuretic peptide (BNP; B) normalized to 18S rRNA in aortic-banded (AB) transgenic (Tg) COOH-terminal G protein-coupled receptor kinase-3 (GRK3ct) mice (GRK3ct-AB mice) and nontransgenic littermate control (NLC) mice (NLC-AB mice) compared with sham-operated (SH) groups (GRK3ct-SH and NLC-SH mice, respectively) 12 wk after AB. AB mice displayed significantly elevated mRNA levels of ␤-MHC versus SH mice, confirming the induction of cardiac hypertrophy, but to a similar degree in GRK3ct-AB versus NLC-AB mice (A). Myocardial mRNA levels of BNP were significantly increased in NLC-AB mice, indicating the progression of cardiac dysfunction (B). In contrast, cardiac BNP mRNA levels in GRK3ct-AB mice were not statistically different from those of GRK3ct-SH mice. †P Ͻ 0.05, GRK3ct-AB vs. NLC-AB mice; *P Ͻ 0.05, NLC-AB vs. NLC-SH mice or GRK3ct-AB vs. GRK3ct-SH mice.
RNA was isolated and purified from myocardial tissue samples (RNeasy kit, Qiagen), and reverse transcription was performed using the TaqMan Reverse Transcription Reagent Kit. Real-time quantitative PCR of each sample was run in triplicate using TaqMan PreDeveloped Assay Reagents and the ABI Prism 7900 Sequence Detection System and software (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions. A standard curve was obtained by amplifications of cDNA obtained from serial dilutions of myocardial total RNA. For all specific mRNA that were amplified, linear inverse correlations were observed between the amount of mRNA and C T value (where CT is the number of cycles at threshold lines). Results were normalized to the levels of 18S rRNA as the housekeeping gene. Myocardial collagen content was determined by HPLC as previously described (1) .
Assay of myocardial ␤AR-stimulated adenylyl cyclase activities and ␤AR densities after chronic pressure overload. Basal, forskolinstimulated, and isoproterenol-stimulated adenylyl cyclase (AC) activities as well as ␤AR densities in cell membranes from myocardial tissue were determined as previously described (17) .
Statistical analysis. Data are presented as means Ϯ SE. Comparisons between groups were made by two-tailed paired and unpaired Student's t-tests or ANOVA where appropriate. P values of Ͻ0.05 were considered statistically significant.
RESULTS

Inhibition of cardiac GRK3 does not alter the afterloadinduced hypertrophic response.
Abdominal AB caused similar pressure gradients across the site of constriction in NLC-AB and GRK3ct-AB mice (change in pressure: 25 Ϯ 3 mmHg in both groups). Significant increases of heart and LV mass were found in AB mice versus SH mice, but no differences between GRK3ct-AB and NLC-AB mice were detected (Table 1) . Two NLC-AB mice and one GRK3ct-AB mouse died during the 12-wk study period. Body weight and weight gain from baseline (not shown) were similar in all study groups ( Table 1) . Induction of cardiac hypertrophy was confirmed by significant elevations of mRNA levels of ␤-myosin heavy chain (␤-MHC) in AB mice versus SH mice (Fig. 1A) . No differences of myocardial ␤-MHC mRNA levels were discerned in GRK3ct-AB versus NLC-AB mice. Moreover, myocardial mRNA levels of brain natriuretic peptide, a biochemical marker of HF and increased wall stress, were increased in NLC-AB mice, indicating a significant progression of cardiac dysfunction (Fig. 1B) . In contrast, cardiac brain natriuretic peptide mRNA levels in GRK3ct-AB mice were low and not statistically different from those of GRK3ct-SH mice.
Tg-GRK3ct mice are prevented from developing cardiac dysfunction after pressure overload. At 6 wk after AB, hearts from AB and SH GRK3ct and NLC mice were excised, perfused ex vivo, electrostimulated at 8 Hz, and subjected to continuous and simultaneous recordings of LV pressure and volume at stepwise increments of filling pressure (Fig. 2) . Significantly increased stroke work, cardiac output, ejection fraction, and dP/dt max were found in hearts from GRK3ct-SH versus NLC-SH mice, confirming the hypercontractile phenotype of GRK3ct mice (38) . NLC-AB mice displayed overt systolic and diastolic cardiac dysfunction, as evidenced by reduced dP/dt max , ejection fraction, stroke work, cardiac output, and dP/dt min compared with NLC-SH mice. These findings were independent of loading conditions, as evidenced by a substantial rightward shift of the LV end-diastolic-and endsystolic pressure-volume relationships (Fig. 3) . In GRK3ct-AB mice, these LV functional parameters were not statistically different from those in GRK3ct-SH mice, indicating that inhibition of GRK3ct increases tolerance toward chronic pressure overload.
Twelve weeks after AB, closed-chest catheterization of the LV and simultaneous steady-state recordings of LV pressure and volume in vivo revealed elevated end-diastolic pressure and reduced ejection fraction in NLC-AB versus NLC-SH mice (all P Ͻ 0.05), consistent with overt cardiac dysfunction ( Table 2 ). These changes were prevented in GRK3ct-AB mice, in which the LV functional cues ejection fraction, cardiac output, and dP/dt max were not statistically different from those of GRK3ct-SH mice.
Myocardial isoproterenol-stimulated AC activities are reduced after chronic pressure overload of NLC hearts. Basal AC activities and forskolin-stimulated AC activities in cell membranes from the LV of NLC-AB hearts were reduced by ϳ20% compared with those from NLC-SH hearts 12 wk after aortic constriction (Fig. 4, A and B) . Isoproterenol-stimulated AC activities were reduced by ϳ50% in cell membranes from the LV of NLC-AB hearts compared with those from NLC-SH hearts after 12 wk with chronic pressure overload (Fig. 4, A and  B) . No significant differences in LV basal AC activities as well as isoproterenol-and forskolin-stimulated AC activities were found between GRK3ct-AB and GRK3ct-SH hearts. Radioligand binding assays for ␤AR densities in cell membranes from the LV did not reveal significant differences between groups (NLC-AB: 18.8 Ϯ 2.5 fmol/mg protein, GRK3ct-AB: 22.9 Ϯ 2.5 fmol/mg protein, NLC-SH: 20.0 Ϯ 4.1 fmol/mg protein, and GRK3ct-SH: 20.0 Ϯ 4.5 fmol/mg protein).
Assessment of cardiac hypertrophy and myocardial fibrosis. Histological analysis of hematoxylin and eosin-stained cardiac sections revealed modest and similar degrees of concentric hypertrophy in both NLC-AB and GRK3ct-AB mice compared OE, NLC-SH; , GRK3ct-SH; , NLC-AB; ' , GRK3ct-AB. *P Ͻ 0.05, NLC-AB vs. GRK3ct-AB mice; †P Ͻ 0.05, NLC-AB vs NLC-SH mice; ‡P Ͻ 0.05, GRK3ct-SH vs. NLC-SH mice at the same filling pressure. Data are from same experiments as in Fig. 2 . A clear rightward shift of the curves can be seen in NLC-AB mice, indicating systolic dysfunction. Moreover, the enhanced systolic function in GRK3ct-SH versus NLC-SH mice confirms previously reported intrinsic hypercontractility. with their respective SH groups (Fig. 5, A and B) . Myocardial collagen contents determined by quantitative HPLC analysis of myocardial hydroxyproline were significantly increased in NLC-AB compared with NLC-SH mice (Fig. 6A) , whereas no significant differences were found between GRK3ct-AB and GRK3ct-SH mice. Moreover, normalized to their respective SH groups, myocardial collagen content was significantly higher in the NLC-AB group compared with the GRK3ct-AB group (Fig. 6B ).
DISCUSSION
To our best knowledge, the present study is the first report on the effects of myocardial GRK3 inhibition in cardiovascular disease. By using mice with cardiac-specific expression of the COOH-terminal membrane-targeting domain, we adopted a proven strategy to inhibit endogenous GRK3 (16) . At baseline, Tg-GRK3ct mice are characterized by hypercontractile hearts due to increased ␣ 1 AR signaling despite no detectable changes in cardiac mass, a finding also confirmed in this study (GRK3ct-SH vs. NLC-SH mice) (38) . After chronic pressure overload, no alterations in the hypertrophic response could be discerned in GRK3ct mice. A key finding in this report is that cardiac function, as assessed comprehensively both in vivo and ex vivo, was preserved in banded Tg-GRK3ct mice compared with banded NLC mice.
GRK2, the most abundant GRK in myocardial tissue (31), has been extensively studied and found to be robustly induced in a variety of cardiac disease models (myocardial hypertrophy, myocardial ischemia, hypertension, and HF) as well as in human HF (2, 21, 25, 30) . Cardiac-specific expression of the COOH-terminal membrane-targeting domain of GRK2 in transgenic mice (␤ARK1ct/Tg-GRK2ct) has been extensively used as a strategy to inhibit endogenous GRK2 and has been shown to rescue cardiac function in various HF models (10, 16, 28, 29, 32, 40) . In particular, overexpression of GRK2ct under control of the ␣-MHC promoter in mice has been found to improve cardiac function after pressure overload according to the level of transgene expression (33) . The cardiac ankyrin repeat protein (CARP) promoter has been used to study the effects of GRK2ct at expression levels determined by the level of fetal gene program induction and degree of pathological hypertrophy. These studies have revealed that physiological, i.e., CARP promoter-controlled, induction of GRK2ct in mice preserves ␤-adrenergic responsiveness in pressure-overloaded cardiac hypertrophy (20) .
Although extensive studies of cardiac GRK2 have uncovered an important role of this kinase in HF, few have focused on the role of myocardial GRK3. GRK2 and GRK3 are highly homologous enzymes but differ substantially in their COOHterminal domain (Ͻ50% homology). A previous report (37) from our laboratory demonstrated the presence of both GRK2 and GRK3 in cardiac myocytes in similar amounts; however, the actual substrate specificities have been unknown until recently. Studies from our laboratory on the substrate specificities of cardiomyocyte GRK2 and GRK3 have demonstrated striking differences at receptor selectivities among these two kinases. Whereas GRK2 acts upon ␤ARs, GRK3 efficiently targets ET receptors and ␣ 1 ARs (36). This difference in receptor selectivity corroborates findings from mice with cardiacrestricted overexpression of GRK3, where no effects of isoproterenol stimulation on contractility were found (14) . As opposed to GRK2, GRK3 prevents cardiac hypertrophy in transgenic mice overexpressing wild-type ␣ 1B ARs or constitutively active mutant ␣ 1B ARs, indicating in vivo receptor selectivity in cardiac myocytes (9) . Consistent with these data, we (38) have recently demonstrated increased contractility Fig. 4 . Isoproterenol-and forskolin-stimulated adenylyl cyclase (AC) activities in LV membranes of AB and SH GRK3ct and NLC mice. Data are displayed as actual isoproterenol-stimulated AC activities (A) and as isoproterenol-stimulated activities as the percent above basal activities (B) as well as basal (C) and forskolin-stimulated (D) AC activities. LV isoproterenol-and forskolin-stimulated AC activities were both significantly lower in NLC-AB mice compared with NLC-SH mice. As basal AC activity (C) was similarly decreased in these animals, normalized data (B) were not different. The reduction of both basal and forskolin-stimulated AC activities in NLC-AB mice is consistent with and indicative of ␤-adrenergic receptor (␤AR) desensitization. No significant differences were found between GRK3ct-AB and GRK3ct-SH mice, consistent with intact ␤AR responsiveness, i.e., absence of relevant ␤AR desensitization. Data are means Ϯ SE of n ϭ 8 mice/group. *P Ͻ 0.05, NLC-AB vs. NLC-sham.
without cardiac hypertrophy in Tg-GRK3ct mice and found evidence for enhanced ␣ 1 AR signaling. Hearts from TgGRK3ct mice showed increased phosphorylation of ERK1/2 and increased hypertrophic responses upon phenylephrine stimulation compared with NLC mice but, importantly, no enhancement of isoproterenol-induced hypertrophy. In the present study, whereas GRK3ct prevented the reduction of ␤AR responsiveness to isoproterenol after chronic pressure overload, myocardial ␤AR densities were not different among the groups, providing evidence that GRK3ct prevented evolving HF during chronic pressure overload. The apparent lack of GRK3ct to augment afterload-induced hypertrophy above that observed in banded NLC mice deserves further comment. This behavior resembles indeed that of banded transgenic mice with either low cardiac expression or CARP promoter-controlled expression of GRK2ct (20, 33) . Thus, neither GRK2 nor GRK3 inhibition impacts on pathological hypertrophic signaling, despite robust preservation of cardiac contractility. One readily available explanation might be a concomitant GRK3ct-mediated enhancement of prohypertrophic pathways, such as via ␣ 1B ARs, being counteracted by beneficial ␣ 1A AR-mediated enhancement of cardiac function in resisting high afterload, resulting in a neutral net effect on cardiac mass. In addition, pressure overload-induced hypertrophy also occurs through the activation of neurohormones such as ANG II and ET-1, mediators that did not evoke enhanced ERK1/2 activation in cardiomyocytes of GRK3ct mice compared NLC mice (38) . The phenotype of Tg-GRK3ct mice is comparable with that of mice with cardiac-specific overexpression of ␣ 1A ARs, which displays hypercontractile hearts in the absence of myocardial hypertrophy (19) . Indeed, these mice also show preserved cardiac function after pressure overload despite an unaltered hypertrophic response and are even protected from LV remodeling after myocardial infarction (7, 8) . Reconstitution of ␣ 1A ARs has been shown to prevent apoptosis in cardiac myocytes from double-knockout ␣ 1A/B AR mice, suggesting a direct protective effect of the ␣ 1A AR subtype (13) . It may thus be speculated whether the beneficial effects of GRK3ct during evolving HF are predominantly mediated through increased ␣ 1A AR responsiveness.
Despite different substrate specificities of myocardial GRK2 and GRK3 both in isolated cells and in vivo, overexpression of GRK3ct seems to attenuate cardiac dysfunction after pressure overload similar to that seen with GRK2ct (20, 33) . An emerging question is to what extent this effect of GRK3ct is due to inhibition of GRK2 or GRK3. In two previous reports (36, 38) , we have investigated the specificity of GRK3ct versus that of GRK2ct at various GPCRs on cardiac myocytes and explored the phenotype of transgenic mice with cardiac-restricted expression of GRK3ct. These resports revealed distinct specificities for GRK2 and GRK3, respectively, which were also reflected at GRK2ct versus GRK3ct. In adult cardiac myocytes, GRK3 desensitized ET receptor-generated and ␣ 1 AR-generated responses, whereas GRK2 did not display efficacy at these receptors. The findings were reflected, for example, by specific GRK3ct-engendered enhancement of ET receptor signaling. For these receptor-generated responses, GRK3ct was specific for GRK3 and GRK2ct was specific for GRK2. However, at ␤AR-generated cAMP synthesis, both GRK2ct and GRK3ct enhanced isoproterenol-stimulated responses, although GRK2ct appeared to be the more efficacious. Thus, at ␤ARs, GRK3ct may inhibit both GRK2 and GRK3 (similarly, GRK2ct may inhibit GRK2 as well as GRK3). However, data from transgenic mice with cardiac-restricted overexpression of GRK3ct demonstrated that in this model (with the levels of GRK3ct found in the cardiac myocytes of these transgenic mice), ␤AR (isoproterenol)-stimulated phospholamban phosphorylation and maximal inotropic responses were not enhanced compared with those of nontransgenic controls (36, 38) . Furthermore, heart rate, as determined by radiotelemetry in awake mice, was similar in Tg-GRK3ct mice and nontransgenic control mice. However, myocardial ␣ 1 ARstimulated responses were found to be enhanced in Tg-GRK3ct mice compared with nontransgenic control mice. Thus, at the levels of GRK3ct present in cardiac myocytes of Tg-GRK3ct mice, we contend that GRK3ct selectively inhibits GRK3. Yet, in general, GRK3ct may not be said to be specific for GRK3, nor that of GRK2ct for GRK2.
The important conclusion of our report is that GRK3ct, through selective inhibition of GRK3 in cardiac myocytes, prevents pressure overload-induced cardiac dysfunction and the evolution to HF. The fact that cardiac ␤ARs are not enhanced in Tg-GRK3ct mice indicates that the attenuation of cardiac dysfunction in GRK3ct-AB mice was not due to boosted ␤-adrenergic signaling. Thus, the reduced desensitization of ␤ARs in Tg-GRK3ct-AB mice versus that of NLC-AB mice simply reflects GRK3ct-mediated prevention of HF in the former group. At the present point, it cannot be excluded that the beneficial effects mediated by overexpression of GRK2ct and GRK3ct, at least partly, rely on common signaling pathways further downstream, including G␤␥-mediated effects. Li and collaborators (18) have reported that phosducin, a G␤␥-binding protein that does not resensitize ␤ARs, is able to increase contractility of failing cardiac myocytes in a similar manner as GRK2ct. This effect occurs without an increase of ␤AR-stimulated cAMP formation. Accordingly, it is reasonable to ask to what extent the effects of GRK2ct could be related to inhibition of G␤␥ rather than ␤AR resensitization. Indeed, a recent report (39) has provided additional evidence for GRK2ct-mediated sequestration of G␤␥. Another important aspect is recent evidence for G␤␥-dependent phosphoinositide 3-kinase (PI3K) activation in cardiac tissue after pressure overload hypertrophy (23) . PI3K has been shown to form a Fig. 6 . LV tissue levels of collagen. A: total collagen levels were significantly higher in NLC-AB mice compared with NLC-SH mice, but no differences between GRK3ct-AB and GRK3ct-SH mice could be discerned. B: normalized to SH levels, collagen levels were significantly higher in NLC-AB mice compared with GRK3ct-AB mice. *P Ͻ 0.05. cytosolic complex with GRK2, which leads to GRK2-mediated translocation of PI3K to the membrane in an agonist-dependent manner (22) . This translocation of PI3K results in a rapid interaction with the receptor, which is of functional importance since inhibition of PI3K activity attenuates ␤AR sequestration. Inhibition of receptor-localized PI3K seems to preserve ␤AR function and ameliorate pressure overload HF as well as an improvement of survival in HF induced by calsequestrin overexpression (24) . Thus, GRK2ct may rescue HF through binding of G␤␥ and not only because of a dominant negative inhibition of GRK2. Since GRK2ct and GRK3ct have a similar capacity to bind and sequestrate G␤␥, we cannot exclude that this mechanism also confers amelioration of cardiac dysfunction in Tg-GRK3ct mice after pressure overload.
In conclusion, cardiac-restricted inhibition of GRK3 in mice attenuates cardiac dysfunction upon pressure overload, preserves LV structure-function relationships, and attenuates myocardial fibrosis, but does not alter the induction of the primary hypertrophic response of the heart to chronic pressure overload per se. It remains to be shown whether GRK3 inhibition halts cardiac dysfunction and the progression to HF in ischemic or dilated cardiomyopathy. Addressing the issue of potential GRK redundancy, further studies will be needed to determine whether dual or selective inhibition of GRK2 and GRK3 would be a superior approach in HF.
